Cargando…
Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times
In the current COVID-19 pandemic, evidence to justify the use of any specific antiviral drug with proven efficacy is not yet available. Antiviral drug development always remains a challenge to the scientists. Remdesivir has emerged as a promising molecule, based on results of clinical trials and obs...
Autores principales: | Choudhury, Shouvik, Chakraborty, Dwaipayan S, Lahiry, Sandeep, Chatterjee, Suparna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482359/ https://www.ncbi.nlm.nih.gov/pubmed/32963442 http://dx.doi.org/10.5005/jp-journals-10071-23491 |
Ejemplares similares
-
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
por: Sarathi Chakraborty, Dwaipayan, et al.
Publicado: (2023) -
Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
por: Choudhury, Shouvik, et al.
Publicado: (2021) -
The National Guidelines for Stem Cell Research (2017): What academicians need to know?
por: Lahiry, Sandeep, et al.
Publicado: (2019) -
Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario
por: Thakur, Sayanta, et al.
Publicado: (2020) -
Impact of social media on academic performance and interpersonal relation: A cross-sectional study among students at a tertiary medical center in East India
por: Lahiry, Sandeep, et al.
Publicado: (2019)